CellaVision Annual Report 2006

2007-04-11 - English

2006 in Figures 
  • Net salses increased by 40% to SEK 54.8 million (39) 
  • Operating loss improved by SEK 7.9 million to -8.6 million (-16.5) and net loss amounted to -8.8 million (-16.7) 
  • Net loss per share amounted to SEK -0.37 million (-0.81) 
  • Liquid amounts were SEK 16.8 million (17.6) by the 31st December, 2006
Significant Events 2006 
  • The exclusive distribution agreements with Sysmex Europe and Sysmex America were extended by three years and several markets were added. 
  • Transfer of production of CellaVision(TM) DM96 to Kitron Flen AB was completed. 
  • ISO-certification was obtained (ISO-13485:2003). 
  • In the Nordic region several hospitals replaced their first CellaVision systems with the most recent generation of systems, CellaVision(TM) DM. 
  • Products were delivered to the first clients in Canada.

PDF version: Annual Report 2006

Subscribe to updates

It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

Click here to register

Information request

Are you looking for some particular information about our company or our business?

Click here to get in touch


ABG Sundal Collier AB
Sten Gustafsson
+46 8 566 286 93

Pareto Securities AB
Christian Lee
+46 8 402 52 67


Access our Student Resources

To access this resource, please provide the following information about yourself.